<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04730310</url>
  </required_header>
  <id_info>
    <org_study_id>H20-03437</org_study_id>
    <nct_id>NCT04730310</nct_id>
  </id_info>
  <brief_title>Anesthesia Technique and Lower Limb Revascularization Patency</brief_title>
  <official_title>Association of Anesthesia Technique With Graft Patency Rates After Open Lower Limb Revascularization: a Retrospective Population Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dr. Xue Chen (Janny) Ke</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. Alana Flexman</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. Stephan Schwarz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. P. Shaun MacDonald</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The role of regional anesthesia in lower extremity revascularization procedures on reducing&#xD;
      graft failure and need for reoperation remains unclear. In this study, we will analyze data&#xD;
      from the multicenter National Surgical Quality Improvement Program (ACS NSQIP®) to assess the&#xD;
      association between regional anesthesia (RA) and graft outcomes, as compared to general&#xD;
      anesthesia (GA). Our primary objective is to determine for patients undergoing elective open&#xD;
      lower limb revascularization, whether RA (spinal, epidural, and peripheral nerve block),&#xD;
      compared to GA or general anesthesia with regional anesthesia (GA+RA), is associated with&#xD;
      higher rates of patent graft within 30 days postoperatively (primary outcome).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lower limb (infrainguinal) revascularization surgeries are performed for patients with blood&#xD;
      flow occlusion, with the goals of improving pain and function. Graft patency is associated&#xD;
      with higher quality of life scores. However, open lower limb revascularization is associated&#xD;
      with a significant risk of graft failure. Multiple anesthesia options exist for elective open&#xD;
      lower limb revascularization, including general and regional (spinal, epidural, peripheral&#xD;
      nerve block). The literature has shown mixed results regarding the superiority of regional&#xD;
      anesthesia over general anesthesia for morbidity and mortality. In this study, we will&#xD;
      analyze data from the multicenter National Surgical Quality Improvement Program (ACS NSQIP®)&#xD;
      to assess the association between regional anesthesia (RA) and graft outcomes, as compared to&#xD;
      general anesthesia (GA).Our primary objective is to determine for patients undergoing&#xD;
      elective open lower limb revascularization, whether RA (spinal, epidural, and peripheral&#xD;
      nerve block), compared to GA or general anesthesia with regional anesthesia (GA+RA), is&#xD;
      associated with higher rates of patent graft within 30 days postoperatively (primary&#xD;
      outcome). Our secondary outcomes are major reintervention, amputation, bleeding requiring&#xD;
      transfusion or secondary procedure, venous thromboembolism (VTE), myocardial infarction (MI)&#xD;
      or stroke, pneumonia, discharge destination, postoperative length of stay, readmission rate,&#xD;
      and death, all within 30 days postoperatively. There will be two composite outcomes:&#xD;
      thromboembolism, and morbidity and mortality. We hypothesize that the use of RA is associated&#xD;
      with increased graft patency after elective lower limb revascularization compared to GA.&#xD;
      Compared to GA, RA is associated with decreased rates of major reintervention, amputation,&#xD;
      death (30 days), bleeding requiring transfusion or secondary procedure, VTE, MI or stroke,&#xD;
      pneumonia, mortality, composite thromboembolism, and composite morbidity and mortality.;&#xD;
      Compared to GA, RA is associated with increased rates of discharge destination being home.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Graft Patency</measure>
    <time_frame>30 days</time_frame>
    <description>Derived using NSQIP variables &quot;Most Severe Procedural Outcome&quot; LEO_MOSTSEVOUTCOME and &quot;Untreated Loss of Patency&quot; (i.e. not patent and no procedure done) LEO_ULP&#xD;
Yes if LEO_MOSTSEVOUTCOME is any of&#xD;
Clinically Patent Graft&#xD;
Patent graft, no stenosis&#xD;
Patent graft with stenosis&#xD;
No if LEO_MOSTSEVOUTCOME is any of&#xD;
Death&#xD;
Image-proven graft thrombosis or clinically evident thrombosis with no planned intervention&#xD;
Major Amputation&#xD;
New bypass in the treated arterial segment&#xD;
Not documented&#xD;
Other&#xD;
Revised graft with stenosis&#xD;
Revised graft, no current stenosis&#xD;
No if LEO_ULP = &quot;yes&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major reintervention</measure>
    <time_frame>30 days</time_frame>
    <description>1. Major reintervention, using NSQIP variable &quot;Major Reintervention on the Bypass&quot; defined as &quot;&quot;Yes&quot; if the patient underwent a subsequent procedure (new or revision lower extremity bypass operation, jump/interposition graft revision, bypass graft thrombectomy/thrombolysis) within 30 days of the original primary operation.&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amputation</measure>
    <time_frame>30 days</time_frame>
    <description>2. Amputation, using NSQIP variable &quot;Major Amputation (Transtibial or Proximal)&quot;, defined as &quot;&quot;Yes&quot; if the patient underwent transtibial or more proximal amputation on the ipsilateral leg within 30 days of the original primary operation.&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding requiring transfusion</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Venous thromboembolism</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MI or stroke</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pneumonia</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of postoperative hospital stay</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge destination</measure>
    <time_frame>30 days</time_frame>
    <description>dichotomize as home vs. not home</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>death</measure>
    <time_frame>30 days or in-hospital admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite thromboembolism</measure>
    <time_frame>30 days</time_frame>
    <description>combination of venothromboembolism, MI, stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite Morbidity and Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>combination of bleeding requiring transfusion, venothromboembolism, MI, stroke, pneumonia, death</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Confounders</measure>
    <time_frame>day of surgery</time_frame>
    <description>age, bleeding diathesis, severe COPD, total operating, time, renal failure, functional status, cardiac valvular disease, diabetes</description>
  </other_outcome>
  <other_outcome>
    <measure>Confounders</measure>
    <time_frame>day of surgery</time_frame>
    <description>INR, PTT</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">15000</enrollment>
  <condition>Regional Anesthesia, Vascular Grafting, Vascular Patency</condition>
  <arm_group>
    <arm_group_label>Regional Anesthesia (RA)</arm_group_label>
    <description>RA&#xD;
Includes spinal, epidural, peripheral nerve block, excludes local infiltration (unlikely that any major open revascularization can be done under local)&#xD;
Defined as: NSQIP Principal (ANESTHES) or additional (ANESTHES_OTHER) anesthesia technique = regional, spinal, epidural, or MAC (in NSQIP RA/Spinal/Local + MAC are coded as MAC; while this includes local + MAC, it would be unlikely that local anesthesia would be sufficient for open revascularization)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General Anesthesia (GA)</arm_group_label>
    <description>GA&#xD;
Defined as: NSQIP Principal or additional anesthesia technique = general&#xD;
Since GA is selected as the principal anesthetic technique by default when multiple techniques are present, GA + RA could potentially have been coded as GA if the optional variable of additional anesthesia technique is not filled in, leading to differential misclassification of patients with GA + RA (most likely epidural and peripheral nerve block) in the GA group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>NSQIP Lower Extremity Open (LEO) procedure-targeted dataset (i.e. undergoing Lower extremity open revascularization) from 2014-2019</intervention_name>
    <description>Infrainguinal, open lower extremity revascularization procedures</description>
    <arm_group_label>General Anesthesia (GA)</arm_group_label>
    <arm_group_label>Regional Anesthesia (RA)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All elective cases within the NSQIP Lower Extremity Open (LEO) procedure-targeted dataset&#xD;
        (i.e. undergoing Lower extremity open revascularization) from 2014-2019 will be included.&#xD;
        The estimated sample size is 15,000 based on the NSQIP Participant Use Files.&#xD;
&#xD;
        Elective procedures will be identified using the NSQIP variable ELECTSURG=1. Urgent and&#xD;
        emergency procedures are not included, as patients may not being offered RA due to&#xD;
        insufficient time and/or unable to withhold anticoagulants/antiplatelets due to acute limb&#xD;
        ischemia. Note that age 18 years and older is already part of the NSQIP inclusion criteria.&#xD;
        Hybrid procedures (where patients had both open and endovascular repair) are included, as&#xD;
        long as there is an open component.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All elective cases within the NSQIP Lower Extremity Open (LEO) procedure-targeted&#xD;
             dataset (i.e. undergoing Lower extremity open revascularization) from 2014-2019 will&#xD;
             be included.&#xD;
&#xD;
          -  Hybrid procedures (where patients had both open and endovascular repair) are included,&#xD;
             as long as there is an open component.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients will be excluded if they underwent urgent or emergency surgery (identified&#xD;
             using NSQIP variable EMERGNCY=1 OR ELECTSURG=0)&#xD;
&#xD;
          -  local was the only anesthetic technique listed in principal and additional anesthesia&#xD;
             technique.&#xD;
&#xD;
          -  missing data on exposure, procedure name, or status of elective surgery. This includes&#xD;
             having &quot;other&quot; or &quot;unknown&quot; for BOTH principal and additional anesthesia technique&#xD;
&#xD;
          -  Patients with INR &gt;= 1.5 on day of surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xue C Ke, MD</last_name>
    <phone>778-222-3786</phone>
    <email>jannyke@alumni.ubc.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christopher P Prabhakar, MD</last_name>
    <phone>778-839-5720</phone>
    <email>christopher.prabhakar@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Barbosa FT, Jucá MJ, Castro AA, Cavalcante JC. Neuraxial anaesthesia for lower-limb revascularization. Cochrane Database Syst Rev. 2013 Jul 29;(7):CD007083. doi: 10.1002/14651858.CD007083.pub3. Review.</citation>
    <PMID>23897485</PMID>
  </reference>
  <reference>
    <citation>Nguyen LL, Moneta GL, Conte MS, Bandyk DF, Clowes AW, Seely BL; PREVENT III Investigators. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg. 2006 Nov;44(5):977-83; discussion 983-4.</citation>
    <PMID>17098529</PMID>
  </reference>
  <reference>
    <citation>Grip O, Wanhainen A, Michaëlsson K, Lindhagen L, Björck M. Open or endovascular revascularization in the treatment of acute lower limb ischaemia. Br J Surg. 2018 Nov;105(12):1598-1606. doi: 10.1002/bjs.10954. Epub 2018 Jul 25.</citation>
    <PMID>30043994</PMID>
  </reference>
  <reference>
    <citation>Ghanami RJ, Hurie J, Andrews JS, Harrington RN, Corriere MA, Goodney PP, Hansen KJ, Edwards MS. Anesthesia-based evaluation of outcomes of lower-extremity vascular bypass procedures. Ann Vasc Surg. 2013 Feb;27(2):199-207. doi: 10.1016/j.avsg.2012.04.006. Epub 2012 Sep 1.</citation>
    <PMID>22944010</PMID>
  </reference>
  <reference>
    <citation>Sgroi MD, McFarland G, Mell MW. Utilization of regional versus general anesthesia and its impact on lower extremity bypass outcomes. J Vasc Surg. 2019 Jun;69(6):1874-1879. doi: 10.1016/j.jvs.2018.08.190. Epub 2019 Feb 18.</citation>
    <PMID>30792062</PMID>
  </reference>
  <reference>
    <citation>Fereydooni A, O'Meara T, Popescu WM, Dardik A, Ochoa Chaar CI. Utilization and Outcomes of Local Anesthesia and Peripheral Nerve Block for Hybrid Lower Extremity Revascularization. J Endovasc Ther. 2020 Feb;27(1):94-101. doi: 10.1177/1526602819887382. Epub 2019 Nov 20.</citation>
    <PMID>31746264</PMID>
  </reference>
  <reference>
    <citation>Roberts DJ, Nagpal SK, Kubelik D, Brandys T, Stelfox HT, Lalu MM, Forster AJ, McCartney CJ, McIsaac DI. Association between neuraxial anaesthesia or general anaesthesia for lower limb revascularisation surgery in adults and clinical outcomes: population based comparative effectiveness study. BMJ. 2020 Nov 25;371:m4104. doi: 10.1136/bmj.m4104.</citation>
    <PMID>33239330</PMID>
  </reference>
  <reference>
    <citation>Christopherson R, Beattie C, Frank SM, Norris EJ, Meinert CL, Gottlieb SO, Yates H, Rock P, Parker SD, Perler BA, et al. Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology. 1993 Sep;79(3):422-34.</citation>
    <PMID>8363066</PMID>
  </reference>
  <reference>
    <citation>Wiis JT, Jensen-Gadegaard P, Altintas Ü, Seidelin C, Martusevicius R, Mantoni T. One-week postoperative patency of lower extremity in situ bypass graft comparing epidural and general anesthesia: retrospective study of 822 patients. Ann Vasc Surg. 2014 Feb;28(2):295-300. doi: 10.1016/j.avsg.2013.01.027. Epub 2013 Sep 29.</citation>
    <PMID>24084268</PMID>
  </reference>
  <reference>
    <citation>Jorgensen MS, Farres H, James BLW, Li Z, Almerey T, Sheikh-Ali R, Clendenen S, Robards C, Erben Y, Oldenburg WA, Hakaim AG. The Role of Regional versus General Anesthesia on Arteriovenous Fistula and Graft Outcomes: A Single-Institution Experience and Literature Review. Ann Vasc Surg. 2020 Jan;62:287-294. doi: 10.1016/j.avsg.2019.05.016. Epub 2019 Aug 2. Review.</citation>
    <PMID>31382001</PMID>
  </reference>
  <reference>
    <citation>Gao C, Weng C, He C, Xu J, Yu L. Comparison of regional and local anesthesia for arteriovenous fistula creation in end-stage renal disease: a systematic review and meta-analysis. BMC Anesthesiol. 2020 Aug 31;20(1):219. doi: 10.1186/s12871-020-01136-1.</citation>
    <PMID>32867692</PMID>
  </reference>
  <reference>
    <citation>Goodney PP, Nolan BW, Schanzer A, Eldrup-Jorgensen J, Bertges DJ, Stanley AC, Stone DH, Walsh DB, Powell RJ, Likosky DS, Cronenwett JL; Vascular Study Group of Northern New England. Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. Ann Vasc Surg. 2010 Jan;24(1):57-68. doi: 10.1016/j.avsg.2009.06.015. Epub 2009 Sep 11.</citation>
    <PMID>19748222</PMID>
  </reference>
  <reference>
    <citation>Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009 May 5;150(9):604-12. Erratum in: Ann Intern Med. 2011 Sep 20;155(6):408.</citation>
    <PMID>19414839</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 25, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2021</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Christopher Prabhakar</investigator_full_name>
    <investigator_title>Clinical Assistant Professor, Deparment of Anesthesiology, Pharmacology and Therapeutics</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>NSQIP data would be free to other researchers from central site.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

